(Q33456964)

English

A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

author name string

Magrath I

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sandlund J

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Raynor A

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rosenberg S

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Arasi V

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Miser J

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

18 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S25-8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ifosfamide in experimental tumor systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The CESS 81 cooperative Ewing sarcoma study of the Society for Pediatric Oncology: an interim report]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Chemotherapy in advanced sarcomas (author's transl)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anticancer spectrum of ifosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00647446

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33456964&oldid=2195381511"